Dupilumab in children aged 6 to <12 years significantly improves severe atopic dermatitis: results from phase 3 trial (LIBERTY AD PEDS)

M. Gooderham,M. Boguniewicz,L. Sher,J. Weisman,A. Bansal,H. W. Staudinger, R. Worrell,N. Patel,N. M. H. Graham,M. Ruddy,X. Sun,B. Beazley,B. Shumel

AUSTRALASIAN JOURNAL OF DERMATOLOGY（2021）

引用 0|浏览27
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要